23 de mayo de 2019
26 de junio de 2008

European Approval for Roche's Pegasys Personalises Treatment for a Subgroup of Hepatitis C Patients: Chance for Cure Wit

(8). World Health Organization. Initiative for Vaccine Research, Viral Cancers, Hepatitis C. 2006. (Accessed July 24, 2006, at http://www.who.int/vaccine_research/diseases/viral_cancers/e....)

Roche Group Media Office: Phone: +41-61-688-8888, Email: basel.mediaoffice@roche.com, Daniel Piller (Head), Alexander Klauser, Martina Rupp, Claudia Schmitt, Nina Schwab-Hautzinger